Moreover, Bauer et al. (2023) provided a more detailed perspective, showing CD73 expression in 21.1% of tumor cells and 42.9% of immune cell infiltrates (TPS ≥ 1%), with the highest rates observed in specific subtypes such as MEC (30%), ACC (29%), and PLGA (33%) [8]. Here, NT5E is linked to neoplasm.